A Mitochondria‐Specific Nanomedicine for Synergistic Chemo‐Photothermal Therapy and Immunogenic Activation Against Breast Cancer
Authors:
Open Access
- 25 February 2026
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (29) , e22226
Abstract
The presence of “cold” tumors in the tumor site is characterized with poor immune cell infiltration and resistance to conventional cancer therapies. To address these challenges, we developed an amphiphilic peptide dendrimer‐based multifunctional drug delivery system for integrating photothermal therapy (PTT), chemotherapy, and immunogenic cell death (ICD) to overcome the limitations of single‐modality treatments. Efficient drug delivery via the nanoplatform is realized through improving circulation stability, facilitating accumulation and penetration in tumor tissues, promoting cellular uptake, and accelerating tumor microenvironment‐responsive drug release. The mitochondria‐targeting property is derived from a mitochondria‐specific photothermal agent and a lipophilic cationic structure in the amphiphilic dendrimer, and it allows selective mitochondrial accumulation and disruption of the mitochondrial function. In vivo and in vitro studies confirm that PTT synergizes with chemotherapy to significantly enhance therapeutic efficacy, effectively induce ICD to modulate the tumor microenvironment, and strengthen antitumor responses. This nanoplatform enhances drug delivery, induces mitochondrial dysfunction, and achieves potent therapeutic effects, therefore, it could be fine‐tuned to become versatile for combination cancer therapies.Keywords
Funding Information
- National Natural Science Foundation of China (51703245)
- Natural Science Foundation of Fujian Province (2024J01499)
This publication has 53 references indexed in Scilit:
- A Nanoimmunoactivator Induces Endoplasmic Reticulum Stress and Alleviates the Immunosuppression for Synergistic Cancer ImmunotherapyAdvanced Functional Materials, 2025
- Biomimetic Tumor Cell Membrane‐Encapsulated Nanoparticles Combine NIR‐II Photothermal Therapy and Chemotherapy for Enhanced Immunotherapy in Triple‐Negative Breast CancerAdvanced Functional Materials, 2024
- Mitochondria‐Targeted Photodynamic and Mild‐Temperature Photothermal Therapy for Realizing Enhanced Immunogenic Cancer Cell Death via Mitochondrial StressAdvanced Functional Materials, 2023
- Recent Advances and Clinical Potential of Near Infrared Photothermal Conversion Materials for Photothermal Hepatocellular Carcinoma TherapyAdvanced Functional Materials, 2023
- Light‐Driven Self‐Recruitment of Biomimetic Semiconducting Polymer Nanoparticles for Precise Tumor Vascular DisruptionAdvanced Materials, 2023
- Immunotherapeutic Hydrogel with Photothermal Induced Immunogenic Cell Death and STING Activation for Post‐Surgical TreatmentAdvanced Functional Materials, 2023
- In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer TherapyAdvanced Materials, 2023
- Design of Calixarene‐Based ICD Inducer for Efficient Cancer ImmunotherapyAdvanced Functional Materials, 2023
- A Self‐Reporting Fluorescent Salicylaldehyde–Chlorambucil Conjugate as a Type‐II ICD Inducer for Cancer VaccinesAdvanced Materials, 2022
- PEGylated Micelle Nanoparticles Encapsulating a Non‐Fluorescent Near‐Infrared Organic Dye as a Safe and Highly‐Effective Photothermal Agent for In Vivo Cancer TherapyAdvanced Functional Materials, 2013